Czechia· CZ-0198026

ORLISTAT SANDOZ

A orlistat product containing orlistat, registered in Czechia by Sandoz s.r.o., Praha. The same ATC class is registered in 16 of our 19 countries.

ATC A08AB01

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedORLISTAT SANDOZATCA08AB01REGISTER NO.CZ-0198026PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Orlistat is registered in 16 of 19 countries.

Countries holding a registration under ATC A08AB01 (orlistat), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 9 of them publish a price we can compare per daily dose

Orlistat · ATC A08AB01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of orlistat costs, country by country.

Normalised to the WHO defined daily dose (0.36 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Orlistat · price per daily dose (0.36 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.08
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Active substance
ORLISTAT
Manufacturer
Sandoz s.r.o., Praha
Country
Czechia (CZ)
ATC code
A08AB01
ATC class
Orlistat
Defined daily dose
0.36 g, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

374 interactions on record for orlistat.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Orlistat · interactions on record

374 records

  • 9 severe
  • 117 moderate
  • 8 minor
  • 238 info

Most severe, free to view

  • TriheptanoinA16AX17severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Orlistat in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All orlistat products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Belgium · Orlistat Sandoz, Orlistat Teva
  • Germany · Orlistat 1 A Pharma, Orlistat Hexal
  • Denmark · Orlistat Accord, Orlistat Rivopharm
  • Estonia · Orlistat Sandoz
  • Spain · Beacita, Elimens
  • Finland · Orlistat Sandoz, Orlistat Stada
  • France · Orlistat Eg
  • United Kingdom (Northern Ireland) · Orlistat, Orlistat Accord-Uk
  • Ireland · Orlistat Accord
  • Iceland · Alli, Xenical
  • Italy · Beacita
  • Liechtenstein · Alli, Xenical
  • Lithuania · Orlistat Polpharma
  • Latvia · Orlistat Polpharma
  • Netherlands · Orlistat Sandoz
  • Norway · Alli, Orlistat Accord
  • Portugal · Orlistato Beacita, Orlistato Ciclum
  • Sweden · Beacita, Orlistat Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b3b7743c-2655-4e48-be01-96a72772076c
GET /v1/drugs/b3b7743c-2655-4e48-be01-96a72772076c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "CPS DUR",
  "source": "sukl",
  "strength": "60MG",
  "pack_size": "21 II",
  "substance": "ORLISTAT",
  "cz_kod_sukl": "0198026",
  "product_type": "CH",
  "substance_codes": "10917",
  "registration_state": "R",
  "registration_number": "08/698/11-C"
}

See everything about orlistat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.